Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (521-530 of 561) with videos related to

Pageof 57
Sort By:
BJU International|March 20, 2026
Refining BCG-failure classifications in non-muscle-invasive bladder cancerAleksander Ślusarczyk, Pietro Scilipoti, Roberto Contieri, et al.
European Urology Open Science|June 17, 2025
Prevalence and Prognostic Significance of Preoperative Anemia in Radical Cystectomy Patients: A Multicenter Retrospective Observational StudyErnest Kaufmann, Luca Antonelli, Luca Afferi, et al.
BJU International|July 4, 2024
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleedingLuca Antonelli, Pedro David Wendel-Garcia, Manja Deforth, et al.
BJU International|March 26, 2025
The impact of histopathological evaluation at transurethral resection of bladder tumour on survival in radical cystectomy candidatesMario de Angelis, Pietro Scilipoti, Alfonso Santangelo, et al.
World Journal of Urology|July 23, 2025
Oncological outcomes of open versus minimally invasive nephroureterectomy for locally advanced upper tract urothelial carcinomaLuca Afferi, Benjamin Pradere, Andrea Gallioli, et al.
Minerva Urology and Nephrology|September 20, 2023
Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapyRadosław Piszczek, Wojciech Krajewski, Jose D Subiela, et al.
BJU International|February 26, 2026
Impact of BCG failure patterns on efficacy of intravesical gemcitabine/docetaxel in high-risk non-muscle-invasive bladder cancerPietro Scilipoti, Paolo Zaurito, Mattia Longoni, et al.
Annals of Surgical Oncology|March 21, 2026
Bladder Tumor Location Matters: Trigone and Bladder Neck Involvement Predict Worse Oncological Outcomes in High-Grade Non-Muscle-Invasive Bladder CancerAleksander Ślusarczyk, Marco Moschini, Wojciech Krajewski, et al.
Urologic Oncology|February 26, 2022
Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy?Alessia Cimadamore, Chiara Lonati, Ettore Di Trapani, et al.
European Urology Oncology|June 24, 2026
Predicting the Development of BCG-unresponsive Disease Among Patients with High-grade Non-muscle-invasive Bladder Cancer: An International Multicenter AnalysisAleksander Ślusarczyk, Marco Moschini, Wojciech Krajewski, et al.
Pageof 57

Showing results (521-530 of 561) with videos related to

Sort By:
Pageof 57
BJU International|March 20, 2026
Refining BCG-failure classifications in non-muscle-invasive bladder cancerAleksander Ślusarczyk, Pietro Scilipoti, Roberto Contieri, et al.
European Urology Open Science|June 17, 2025
Prevalence and Prognostic Significance of Preoperative Anemia in Radical Cystectomy Patients: A Multicenter Retrospective Observational StudyErnest Kaufmann, Luca Antonelli, Luca Afferi, et al.
BJU International|July 4, 2024
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleedingLuca Antonelli, Pedro David Wendel-Garcia, Manja Deforth, et al.
BJU International|March 26, 2025
The impact of histopathological evaluation at transurethral resection of bladder tumour on survival in radical cystectomy candidatesMario de Angelis, Pietro Scilipoti, Alfonso Santangelo, et al.
World Journal of Urology|July 23, 2025
Oncological outcomes of open versus minimally invasive nephroureterectomy for locally advanced upper tract urothelial carcinomaLuca Afferi, Benjamin Pradere, Andrea Gallioli, et al.
Minerva Urology and Nephrology|September 20, 2023
Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapyRadosław Piszczek, Wojciech Krajewski, Jose D Subiela, et al.
BJU International|February 26, 2026
Impact of BCG failure patterns on efficacy of intravesical gemcitabine/docetaxel in high-risk non-muscle-invasive bladder cancerPietro Scilipoti, Paolo Zaurito, Mattia Longoni, et al.
Annals of Surgical Oncology|March 21, 2026
Bladder Tumor Location Matters: Trigone and Bladder Neck Involvement Predict Worse Oncological Outcomes in High-Grade Non-Muscle-Invasive Bladder CancerAleksander Ślusarczyk, Marco Moschini, Wojciech Krajewski, et al.
Urologic Oncology|February 26, 2022
Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy?Alessia Cimadamore, Chiara Lonati, Ettore Di Trapani, et al.
European Urology Oncology|June 24, 2026
Predicting the Development of BCG-unresponsive Disease Among Patients with High-grade Non-muscle-invasive Bladder Cancer: An International Multicenter AnalysisAleksander Ślusarczyk, Marco Moschini, Wojciech Krajewski, et al.
Pageof 57